Cohort Company News - MedTech Innovator

HD Medical Awarded FDA Clearance For HD Steth

DateJul 14 2020

HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth utilizes cutting-edge AI technology to enable clinicians to perform advanced cardiac evaluation at the point-of-care to save time and lives.

Forest Devices Launches Collaboration With Alberta Health Services

DateJun 30 2020

Medical technology pioneer Forest Devices, Inc. (FDI) today announced a commitment to improve healthcare delivery for stroke patients in Alberta, forming a collaboration with Alberta Health Services (AHS) to evaluate and test technologies that can improve patient outcomes and health system performance by empowering emergency first responders to make informed decisions regarding care for stroke patients.

SidekickHealth secures multimillion-dollar deal with Pfizer

DateJun 29 2020

The firms are collaborating to launch a digital medication management and lifestyle platform across Europe.

Medable Partners With Datavant to Simplify Integration of Data Sources for Decentralized Clinical Trials

DateJun 29 2020

Medable Inc., the leading software provider for decentralized clinical trials, and Datavant, the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.

20 medical device startups you need to know

DateJun 26 2020

Here’s a roundup of 20 medical device startups catching the eye of Medical Design & Outsourcing and MassDevice editors this year where MedTech Innovator companies are the majority.

OrthoGrid Systems Partners with Osso VR

DateJun 19 2020

This partnership allows surgeons to become familiar with OrthoGrid’s navigation system and better understand fluoroscopic distortion and its impact on surgical outcomes.

Chicagoland medical device company raises $15 million in Series B funding

DateJun 15 2020

A Chicagoland medical company that makes a device to make it easier for doctors to see in surgery said it's raised $15 in a Series B funding round.Employees formed a limited liability company that contributed $4 million to the funding.

First AR Spine Surgery Using Augmedics xvision Completed in U.S.

DateJun 12 2020

Augmedics’ xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons. Augmedics’ xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons.

Western Ireland’s University Hospital Galway Leading Advanced Heart Failure Monitoring Clinical Trial

DateJun 06 2020

The investigational product, known as the Cordella Sensor from U.S.-based company called Endotronix, detects changes in the health of patients with heart failure while securely transmitting information to the cardiovascular team. With this data in real time, the cardiovascular team can not only receive relevant updates but also can intervene with the goal of preventing heart failure flare-up resulting in emergency hospitalization.

LabCorp Launches Website to Connect Patients with COVID-19 Clinical Trials

DateJun 03 2020

LabCorp also announced that it is partnering with digital clinical trial software maker Medable to allow clinical trial participants to engage with trials remotely. This is expected to help with remote data collection, patient engagement and easier app access for trials.

Bigfoot Biomedical raises $55m in Series C

DateJun 03 2020

Milpitas, Calif.-based Bigfoot said in a news release that the proceeds will support product development and the regulatory pathway for its Bigfoot Unity system as a part of the Bigfoot Unity Diabetes Management Program.

Fibralign Announces Strategic Partnership With Terumo

DateJun 02 2020

Fibralign Corp., a Stanford spin-out developer of therapeutic biomedical devices, has announced today that it has executed a long term distributor agreement with Terumo Corporation to market and distribute the BioBridge® Collagen Matrix in Japan for treating and preventing secondary lymphedema.

Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense™ Noninvasive Thermal Sensor

DateJun 01 2020

The Breakthrough Device Designation is supported by data from several recently published studies demonstrating effective use of FlowSense in detecting changes in cerebrospinal fluid volume and flow. By receiving this designation, Rhaeos will work in close collaboration with the FDA to streamline the market clearance process of FlowSense for this high-risk patient population.

Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World

DateMay 29 2020

"The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe," said Henry Weinstein, Managing Partner at Benslie International Ltd.

PercuSense Secures DoD Funds for Chemical Exposure Monitoring Tech Dev’t

DateMay 29 2020

The company said Thursday it will use the funds awarded by the Defense Innovation Unit and the Defense Threat Reduction Agency to produce the on-body platform for first responders and military personnel to receive exposure alerts in real time.

Medtech Startup Promaxo Raises First Tranche of Series B-1 Funding

DateMay 28 2020

Promaxo, an Oakland-based medical technology startup developing the portable single-sided MRI, today announced that it has raised the first tranche of Series B-1 funding. The equity round was led by Kineticos Disruptor Fund with participation from existing investors. Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform.

Neural Analytics aims robotic transcranial doppler at COVID-19 patients

DateMay 28 2020

Doctors are reporting a proliferation of dangerous blood clots in the lungs and other major organs of COVID-19 patients, raising the risk of stroke and other life-threatening complications. While anticoagulant medications can reduce that risk, patients need careful monitoring to ensure their blood is neither too thick nor too thin. To that end, Los Angeles-based startup Neural Analytics Inc. is deploying its robotically assisted transcranial doppler (TCD) system for real-time identification of blood clots and disruptions in blood flow to the brain.

FDA greenlights ICU AI for predicting fatal COVID-19 complications

DateMay 28 2020

The company’s CLEWICU artificial intelligence software ingests a large range of patient data by linking to electronic medical records, connected medical devices and vital sign monitors, with no need for additional data entry by ICU staff. The FDA also said the standalone CLEWICU software, based within the hospital or in the cloud, could help reduce contact between healthcare workers and COVID-19 patients through remote monitoring.

Bardy Diagnostics® Announces CE Mark Certification for 14-Day Carnation® Ambulatory Monitor (CAM®) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis

DateMay 26 2020

"CE marking of the 14-Day CAM patch is a significant corporate milestone and a testament to the quality of the CAM patch and BardyDx's compliance with all applicable European health, safety, performance and environmental requirements," said Ed Vertatschitsch, Chief Operating Officer.

Alleviant Medical completes $6.5m offering

DateMay 19 2020

Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering. The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering last longer than one year and did not make it in connection with a business transaction.